Help Your Patients Take Charge. Managing a chronic disease can be complex and frustratingâfor. you and your patients. Give them the tools they need to improve. their health. Recommend a self-management education or physical. activity intervention and help your patients take charge.
Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year. Debbie Byrnes suffered from severe eczema, but her skin is almost completely clear after using Dupixent for two years. The Food and Drug Administration on Tuesday approved a drug to treat people with a serious form of eczema, a potential breakthrough for people who have suffered for years without relief.
It also suggested that Jacobus would seek FDA approval for its version of the LEMS drug. Catalyst has not yet released its projected price for Firdapse, which is sold by BioMarin in Europe for an annual cost of about $60,000 a patient.